Viewing StudyNCT00761384



Ignite Creation Date: 2024-05-05 @ 7:56 PM
Last Modification Date: 2024-10-26 @ 9:55 AM
Study NCT ID: NCT00761384
Status: COMPLETED
Last Update Posted: 2016-02-19
First Post: 2008-09-26

Brief Title: High Dose Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells PBSC Support in B-cell Lymphoma
Sponsor: Lund University Hospital
Organization: Lund University Hospital

Organization Data

Organization: Lund University Hospital
Class: OTHER
Study ID: 6th radioimmunotherapy prot
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Lund University Hospital
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Bayer INDUSTRY